Cargando…

Predictors of Interest in an Alcohol Reduction Clinical Trial of Naltrexone among Undergraduates

BACKGROUND: We tested predictors of interest in a clinical trial of naltrexone plus counseling for heavy drinking reduction in young adults using a web survey. Respondents could indicate interest in the clinical trial at the conclusion of the survey. METHODS: A random sample of university students c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leeman, Robert F, Corbin, William R, Fucito, Lisa M, Urwin, John W, O’Malley, Stephanie S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917969/ https://www.ncbi.nlm.nih.gov/pubmed/24511431 http://dx.doi.org/10.4172/2155-6105.1000151

Ejemplares similares

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

Exploring the Utility of Web-Based Social Media Advertising to Recruit Adult Heavy-Drinking Smokers for Treatment
por: Bold, Krysten W, et al.
Publicado: (2016)

Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
por: Leighty, Anne E., et al.
Publicado: (2019)

Cigarette Smoking in Response to COVID-19: Examining Co-Morbid Medical Conditions and Risk Perceptions
por: Fucito, Lisa M., et al.
Publicado: (2022)

Open Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
por: Colquhoun, Ross M.
Publicado: (2013)

Naltrexone long-acting formulation in the treatment of alcohol dependence
por: Johnson, Bankole A
Publicado: (2007)

Medications for Unhealthy Alcohol Use: Across the Spectrum
por: O’Malley, Stephanie S., et al.
Publicado: (2011)

Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial
por: Galloway, Gantt P, et al.
Publicado: (2005)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

A Multimodal Mobile Sleep Intervention for Young Adults Engaged in Risky Drinking: Protocol for a Randomized Controlled Trial
por: Fucito, Lisa M, et al.
Publicado: (2021)

Views about responsibility for alcohol addiction and negative evaluations of naltrexone
por: Johnson, Rebecca A, et al.
Publicado: (2015)

Naltrexone ameliorates functional network abnormalities in alcohol‐dependent individuals
por: Morris, Laurel S., et al.
Publicado: (2017)

Naltrexone-induced psychosis in a patient with alcohol use disorder
por: Ruei-Yuan, Hu, et al.
Publicado: (2023)

Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response
por: Witkiewitz, Katie, et al.
Publicado: (2019)

Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder
por: Castaldelli-Maia, João M., et al.
Publicado: (2021)

Eating Disorders and Alcohol Use Disorders
por: Grilo, Carlos M., et al.
Publicado: (2002)

Maturing Out of Problematic Alcohol Use
por: O’Malley, Patrick M.
Publicado: (2004)

Undergraduate student nurses’ views of online learning
por: Goodwin, John, et al.
Publicado: (2022)

Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial
por: Witkiewitz, Katie, et al.
Publicado: (2019)

Using Web-Based Social Media to Recruit Heavy-Drinking Young Adults for Sleep Intervention: Prospective Observational Study
por: Ash, Garrett I, et al.
Publicado: (2020)

Naltrexone‐induced drug eruption
por: Heck, Johannes, et al.
Publicado: (2020)

Randomized Controlled Trial of a Mobile Phone Intervention for Improving Adherence to Naltrexone for Alcohol Use Disorders
por: Stoner, Susan A., et al.
Publicado: (2015)

Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: A randomized trial
por: Schacht, Joseph P., et al.
Publicado: (2022)

O-Benzoylnaltrexone
por: Yang, Rui, et al.
Publicado: (2013)

Asymmetric synthesis of (–)-naltrexone
por: Dongbang, Sun, et al.
Publicado: (2018)

Treatment Implications: Using Neuroscience to Guide the Development of New Pharmacotherapies for Alcoholism
por: Krishnan-Sarin, Suchitra, et al.
Publicado: (2008)

The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study
por: Ray, Lara A., et al.
Publicado: (2010)

Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review
por: Ahmed, Rizwan, et al.
Publicado: (2018)

Effectiveness of naltrexone treatment for alcohol use disorders in HIV: a systematic review
por: Farhadian, Negin, et al.
Publicado: (2020)

Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease
por: Ayyala, Divya, et al.
Publicado: (2022)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder
por: Witkiewitz, Katie, et al.
Publicado: (2020)

Naltrexone Initiation in the Inpatient Setting for Alcohol Use Disorder: A Systematic Review of Clinical Outcomes
por: Kirchoff, Robert W., et al.
Publicado: (2021)

Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey
por: Leung, Jonathan G., et al.
Publicado: (2022)

A Pharmacology-Based Enrichment Program for Undergraduates Promotes Interest in Science
por: Godin, Elizabeth A., et al.
Publicado: (2015)

Use and perceptions of electronic nicotine delivery systems among patients attending lung cancer screening who smoke
por: Fucito, Lisa M., et al.
Publicado: (2021)

Supplier-dependent differences in intermittent voluntary alcohol intake and response to naltrexone in Wistar rats
por: Momeni, Shima, et al.
Publicado: (2015)

Effects of naltrexone on alcohol self‐administration and craving: meta‐analysis of human laboratory studies
por: Hendershot, Christian S., et al.
Publicado: (2016)

FMRI-based prediction of naltrexone response in alcohol use disorder: a replication study
por: Bach, Patrick, et al.
Publicado: (2021)

Baclofen and naltrexone, but not N-acetylcysteine, affect voluntary alcohol drinking in rats regardless of individual levels of alcohol intake
por: Minnaard, A. Maryse, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bkpsqtj8qcpdnjjtsjoabdcak